Vanguard Consumer Staples Index Fund Admiral Shares (VCSAX) Dividend Yield, History & Forecast

Vanguard Consumer Staples Index Fund Admiral Shares (VCSAX) is an exchange-traded fund (ETF) listed on the NASDAQ. It pays a current dividend yield of 2.02% ($2.41 per share annually (TTM)). The most recent ex-dividend date was September 23, 2026, with payment scheduled for September 24, 2026. market capitalization is approximately $8.70B. Review VCSAX dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

VCSAX fund composition

VCSAX holds 100 positions, with 66.0% of assets in its ten largest.

Top 10 holdings

HoldingWeight
WMTWalmart Inc13.86%
COSTCostco Wholesale Corp12.12%
PGProcter & Gamble Co/The9.90%
KOCoca-Cola Co/The9.80%
PMPhilip Morris International Inc4.83%
PEPPepsiCo Inc4.28%
MOAltria Group Inc3.86%
MDLZMondelez International Inc2.58%
TGTTarget Corp2.50%
CLColgate-Palmolive Co2.28%

Frequently Asked Questions about Vanguard Consumer Staples Index Fund Admiral Shares (VCSAX)

What is Vanguard Consumer Staples Index Fund Admiral Shares's dividend yield?
Vanguard Consumer Staples Index Fund Admiral Shares (VCSAX) pays a current trailing twelve-month dividend yield of 2.02%, which works out to $2.41 per share annually based on the most recent payout schedule.
When does Vanguard Consumer Staples Index Fund Admiral Shares pay its next dividend?
The most recent ex-dividend date was September 23, 2026. The next scheduled dividend payment date is September 24, 2026.
Is Vanguard Consumer Staples Index Fund Admiral Shares a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Vanguard Consumer Staples Index Fund Admiral Shares in?
Vanguard Consumer Staples Index Fund Admiral Shares (VCSAX) operates in the Financial Services sector, specifically the Asset Management industry.